Farms.com Home   Ag Industry News

Iowa poll shows Clinton has climbed into tie, as Trump says he’ll “end war on farmers”

By Liam Nolan & Paul Nolan

Donald Trump has a wide lead over Hillary Clinton in an Iowa Youth Straw Poll conducted Tuesday, after the Republican candidate visited the state and promised to “end this war on the American farmers.”

According to a report in the Quad City Times, Trump polled 46 per cent to Democrat Clinton’s 36 per cent. More than 57,000 students participated in the poll, which was conducted by the Secretary of State’s office.

In Cedar Rapids on Friday, Trump appeared before thousands of rural voters and claimed that Clinton “will shut down family farms.”

Trump, who told the crowd he had recently pulled ahead in numerous national polls, said that Clinton would hurt farmers with EPA regulations, and by raising estate taxes.

Trump’s claims were not upheld by poll results released on Oct. 27 by Quinnipiac University, which found Trump and Clinton were tied at 44 per cent among Iowa residents.

A month earlier, a Sept. 22 report had Trump ahead by a 44 to 37 per cent margin. Quinnipiac also conducted that poll.


Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.